Ginkgo Bioworks Announces Acquisition Of Massachusetts Covid-19 Testing Provider Project Beacon Covid-19 Llc
Acquiring Company
Ginkgo Bioworks
Acquired Company
Project COVID-19
BostonOtherManufacturingBiotechnologySustainabilitySoftwareScience And EngineeringDescription
Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced the acquisition of Project Beacon COVID-19 LLC (Project Beacon), a Boston-based social benefit organization focused on helping to increase the capacity, availability, accessibility and affordability of COVID-19 testing. Under the terms of the deal, Ginkgo acquired Project Beacon's assets and will assume responsibility for Project Beacon's ongoing operations, providing COVID-19 monitoring tools to communities in Massachusetts and other areas.
Quick answer
Ginkgo Bioworks is acquiring Project COVID-19, announced January 19, 2022. Ginkgo Bioworks is based in Boston, Massachusetts, United States.
- How much did Ginkgo Bioworks pay for Project COVID-19?
- The deal value was not disclosed.
- What does Ginkgo Bioworks do?
- Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to..
- Where are Ginkgo Bioworks and Project COVID-19 based?
- Ginkgo Bioworks is based in Boston, Massachusetts, United States.
- Who are the decision-makers at Ginkgo Bioworks?
- Fundz holds 3 contacts at Ginkgo Bioworks. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Sustainability and Science And Engineering
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Genuine Parts Company Completes Acquisition Of Kaman Distribution Group, Creating A Premier Leader In Industrial Solutions (January 4, 2022)
- 48Forty Solutions Acquires Bo'S Pallets (March 4, 2022)
- Chevron Announces Agreement To Acquire Renewable Energy Group (February 28, 2022)
- Intel To Acquire Tower Semiconductor For $5.4 Billion, $5.4B (February 15, 2022)
- Asymchem Acquires Snapdragon Chemistry (February 11, 2022)
- Intellia Therapeutics Announces Acquisition Of Rewrite Therapeutics (February 3, 2022)
Who to call at Ginkgo Bioworks, and when
When Ginkgo Bioworks changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Ginkgo Bioworks raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ginkgo Bioworks, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ginkgo Bioworks. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ginkgo Bioworks makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Project COVID-19?
Project COVID-19 was acquired by Ginkgo Bioworks, based in Boston. The deal was reported on January 19, 2022. Ginkgo Bioworks is publicly traded (DNA) and operates in Other.
When did Ginkgo Bioworks acquire Project COVID-19?
Ginkgo Bioworks's acquisition of Project COVID-19 was reported on January 19, 2022. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Project COVID-19 do?
Project COVID-19 is the company acquired in this transaction. It is privately held.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.